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Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an efficacious therapy for
Parkinson’s disease (PD) but its effects on non-motor facets may be detrimental. The low-
frequency stimulation (LFS) of the pedunculopontine nucleus (PPN or the nucleus tegmenti
pedunculopontini – PPTg-) opened new perspectives. In our hands, PPTg-LFS revealed a
modest influence on gait but increased sleep quality and degree of attentiveness. At odds
with potential adverse events following STN-DBS, executive functions, under PPTg-ON,
ameliorated. A recent study comparing both targets found that only PPTg-LFS improved
night-time sleep and daytime sleepiness. Chances are that different neurosurgical groups
influence either the PPN sub-portion identified as pars dissipata (more interconnected
with GPi/STN) or the caudal PPN region known as pars compacta, preferentially targeting
intralaminar and associative nucleus of the thalamus.Yet, the wide electrical field delivered
affects a plethora of en passant circuits, and a fine distinction on the specific pathways
involved is elusive. This review explores our angle of vision, by which PPTg-LFS activates
cholinergic and glutamatergic ascending fibers, influencing non-motor behaviors.
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STATE-OF-THE-ART OF MOTOR AND NON-MOTOR EFFECTS
OF PPN-DBS
Deep brain stimulation (DBS) of the Subthalamic nucleus (STN)
has acquired the status of reliable therapy for Parkinson’s disease
(PD) patients (Benabid et al., 2009; Moro et al., 2010a). How-
ever, in recent years, the neurosurgical treatment of movement
disorders has been focused on identifying alternative targets to the
traditional STN, in order to minimize adverse events and to rescue
motor axial signs (Pahapill and Lozano, 2000; Nandi et al., 2002b;
Mena-Segovia et al., 2004; Stefani et al., 2007). In fact, although
the efficacy of STN-DBS on segmental motor symptoms is proved,
other motor features (akinesia, freezing of gait) are relatively resis-
tant to STN-DBS or may even worsen (Kleiner-Fisman et al., 2003;
Rodriguez-Oroz et al., 2005). Incidentally, the benefits promoted
by DBS of the ventromedial tiers of the globus pallidus inter-
nus (GPi), too rapidly abandoned in the nineties, were similar to
those obtained by STN-DBS, and were scarcely impressive on gait
(Rodriguez-Oroz et al., 2005; Follett et al., 2010).
The pedunculopontine nucleus area (PPN-a) represents an
heterogeneous structure placed in the dorso-lateral mesopontine
tegmentum; it consists of a pars compacta and a pars dissipata
and features a complex cells organization, which engages different
population of cholinergic, glutamatergic, and GABAergic neu-
rons (Mena-Segovia et al., 2009; Wang and Morales, 2009). As
known, PPN-a, part of the reticular activating system, plays a crit-
ical role in regulating the sleep-awake cycle and facilitating arousal
mechanisms (Steriade et al., 1990a; Rye, 1997; Datta, 2002). PPN-
a is also strongly involved in other facets of behavior including
motivation, attention, reward, and mnemonic processes (Steckler
et al., 1994; Winn, 2006; Andero et al., 2007; Ros et al., 2010).
In addition, it has been largely inferred that portions of PPN-
a participates in locomotion and contributes to postural tone
as a result of the influence on the lower brainstem and on the
spinal cord, exerted via the pontomedullary reticular formation
and reticulospinal nuclei (Lee et al., 2000; Pahapill and Lozano,
2000; Takakusaki et al., 2003; Mena-Segovia et al., 2004; Pieran-
tozzi et al., 2008). Experimental models proved that “some dorsal
tiers” of the PPN-a, i.e., the traditional mesencephalic locomo-
tor region, induces initiation, and maintenance of locomotion
(Garcia-Rill et al., 1987; Skinner et al., 1990; Takakusaki, 2008),
while its inactivation, by lesion or high frequency stimulation
(HFS), produces akinesia in non-human primates (Munro-Davies
et al., 1999; Nandi et al., 2002b). It should be noted that this form of
experimental akinesia may be reverted by the low-frequency stim-
ulation (LFS) of PPN-a (Nandi et al., 2002a,b; Jenkinson et al.,
2004). Moreover, extensive degeneration of PPN-a occurs in idio-
pathic PD (Hirsch et al., 1987; Pahapill and Lozano, 2000). An
adjourned excursus of the complex functional organization of
PPN region is available in the review by Benarroch (2013).
All this considered, PPN-a was envisioned as a good and safe
candidate for stereotactic neurosurgery in PD patients featuring
prominent and levodopa-resistant axial impairment (Pahapill and
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Lozano, 2000; Mena-Segovia et al., 2004; Pereira et al., 2008). The
pioneering works were performed by an Italian and a British group
(Mazzone et al., 2005; Plaha and Gill, 2005). Mazzone has renamed
further his preferential target as the nucleus tegmenti pedunculo-
pontini (PPTg) (Mazzone et al., 2007, 2008, 2011). For reasons
of clarity, from now on, the definition PPTg will be utilized for
works produced by the Italian specialists, whilst PPN-a will be
maintained for all the others.
Since then, other groups successfully completed the neurosur-
gical procedure targeting either bilateral or mono-lateral PPN-a, in
limited series of selected PD patients. Table 1 illustrates most of the
available works worldwide (choice was not limited to, but oriented
toward, those manuscripts capable to illustrate also non-motor
domains).
The fascinating proposal that PPN-a-LFS might represent the
alternative surgical strategy to manage some Parkinsonian motor
symptoms inadequately responsive to traditional DBS targets, has
not been confirmed in full (Stefani et al., 2007; Ferraye et al.,
2010; Moro et al., 2010b). Recent clinical follow-ups at 2–3 years
reported some uncertainties (Moreau et al., 2009; Peppe et al.,
2010) or a progressive decline of the transient gait amelioration
(in support of likely placebo effect, see Stefani et al., 2009). Despite
these inconsistencies, Mazzone and co-authors have documented
lately a solid procedure in more than 15 patients mono-laterally
implanted in PPTg (thus, a procedure not including the simul-
taneous targeting of STN – consider Table 2 in Mazzone et al.,
2011, from patient 7 to patient 23, plus additional 5 more in
recent months); hence, more extended follow-up in a larger patient
sample is ahead.
Our first observations (Stefani et al., 2007), focused on the
PPTg-LFS (10–25 Hz) in PD patients simultaneously implanted
in STN, showed some disappointing motor results (at least if
compared to 130–185 HFS-STN), but opened new interesting
perspectives in terms of beneficial impact on PD non-motor symp-
toms (NMS), including sleep, attention, and cognitive domains
(Alessandro et al., 2010; Costa et al., 2010).
In the last decade, huge efforts in the neurological community
have been devoted toward detection and classification of NMS in
PD patients, since recognized as a detrimental milestone, which
may dictate patient quality of life (Chaudhuri et al., 2006; Hin-
nell et al., 2012). Accordingly, nowadays the majority of on-going,
long-lasting clinical trials include measures of global cognitive
functioning and psychopathological profiles, especially if designed
to assess the efficacy of complex therapeutic strategies such as DBS
(Witt et al., 2008, 2011). Interestingly, in PD patients undergoing
STN-DBS, the best motor response was not necessarily correlated
to the increase of metabolic activity in frontal cortical areas gov-
erning executive functions. STN-DBS was found to partly restore
physiologic glucose consumption in limbic and associative projec-
tion territories of the basal ganglia, but erratically (Hilker et al.,
2004). Overall, a minimal decline – albeit frequently infra-clinical –
of cognitive and executive functions may occur after STN-DBS
(Parsons et al., 2006; Witt et al., 2008; Daniels et al., 2010). This
figure is hard to attribute in full to the STN-HFS per se, given
the natural PD history, which implies: (a) a continuous decline of
dopaminergic function as the disease progresses, independently of
pharmacological or surgical treatments (Hilker et al., 2005) and
(b) the progressive involvement of other pathways (noradrenergic
and cholinergic ones).
This scientific field around PPN-a is largely perturbed by a
long-lasting debate concerning appropriateness and functional
anatomy of the brain-stem targeting, as we have presented (Maz-
zone et al., 2005, 2008, 2011; Stefani et al., 2007). In our patients,
the stimulation target did in fact correspond to the caudal pon-
tine representation of PPN, which is PPTg (Mazzone et al., 2008;
Insola et al., 2012) and, likely, coincides, at least in part, with
PPN pars compacta (PPN-C, see Figure 1 in Benarroch, 2013).
Contenders have questioned this localization; the Queen’s Square
group proposed, for instance, a careful approach to identify an
ideal stereotactic localization of the nucleus (Zrinzo et al., 2008).
At present, the perfect PPN-DBS surgical strategy still waits for fur-
ther investigations, and we may hope that the academic discussion
avoids some crude, occasionally too informal a tone, recently top-
ping the standard dialectics (Aviles-Olmos et al., 2011; Mazzone
et al., 2012a).
In the patient’s interest, any group is expected to provide
unequivocal correlations between target details and clinical scores.
Mazzone et al. (2011) have recently addressed the potential
ambiguities via a careful reassessment of the target, based upon
an unconventional reconstruction, which overcomes the routine
CA-CP landscape and focuses on dedicated landmarks of the
brain-stem.
Also the Grenoble group provided a patient-by-patient MRI
identification of the target (Ferraye et al., 2010), but acknowl-
edged the variability of the clinical response and the lack of a strict
correlation between catheter positioning and gait performance.
The French school had initially utilized micro-recording through
a rostro-caudal trajectory starting from CA-CP line toward the
“para-cuneiform” region, in which a generous “mimicked gait”-
firing discharge occurred (consider Piallat et al., 2009). However,
similar electrophysiological hallmarks are not shared by others.
For the time being, at least five groups worldwide have chased
the PPN-a as potential target (Table 1). Unfortunately, the lack of
common protocols has hampered from the beginning the chance
to acquire solid conclusions despite the small number’s series. In
particular, cognitive evaluations are not always available or appear
as anecdotal. Also in terms of the motor outcome, so far, results
are inconclusive.
In this scenario, the modest, but consistent, cognitive ameliora-
tion induced by PPN-a-LFS, at least in our patients, is of interest,
representing the core of the following chapters.
PPN-AREA DBS AND SLEEP
Pedunculopontine nucleus area is undoubtedly involved in con-
trolling alternations between behavioral states as the result of
promoting the thalamo-cortical activation that is thought to reg-
ulate both wakefulness and rapid eye movement (REM) sleep in
mammals (Rye, 1997; Pahapill and Lozano, 2000). Not surpris-
ingly, different research groups, who have experienced PPN-DBS
in an attempt to improve Parkinsonian motor symptoms, have
ascertained the impact of 10–70 Hz PPN-stimulation on patients’
sleep quality.
In our hands, PPTg stimulation proved a potent effect on
patient sleep architecture, as originally emphasized by a pioneering
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Table 1 | Selected papers on PD patients implanted in the “PPN-area” (estimated 60 patients from Rome, Bristol, Oxford, Melbourne, Grenoble,
Toronto).
Selected papers Patients DBS targeting
(and follow-up)
Motor symptoms Sleep and cognitive domains
Mazzone et al.
(2005)
N =2 Bilateral PPTg and STN
(1 month)
SAFETY study NA
Plaha and Gill
(2005)
N =2 Bilateral PPN (3 months) Improvement of gait
dysfunction and postural
instability
NA
Stefani et al.
(2007)
N =6 Bilateral PPTg and STN
(6 months)
Significant improvement NA (but surprising intra-operative pleasant arousal )
Lim et al.
(2007)
N =1 Unilat. PPN (acute) N-AP Intrapontine and scalp EEG recordings: evidence of
ponto-geniculo-occipital (PGO) waves in humans
Romigi et al.
(2008)
N =1 Bilateral PPTg and STN N-AP First polysomnographic (PSG) recordings: relevant
increase in REM sleep (note: from the same series of
Stefani et al., 2007)
Lim et al.
(2009)
3 PD;2 PSP Unilat. PPN
(post-surgery)
N-AP PSG study: strong modulation of REM sleep
Zanini et al.
(2009)
N =5 Bilateral PPTg and STN
(1 year)
(See Stefani et al., 2007) Improvement of the grammatical aspect of language
(Note: from the same series of Stefani et al., 2007)
Ceravolo et al.
(2011)
N =6 Bilateral PPTg and STN
(1 year)
(See Stefani et al., 2007) Improved executive functions; increased FDG
consumption in prefrontal areas and mono-lateral ventral
striatum (see Figure 2)
Peppe et al.
(2010)
N =5 Bilateral PPTg and STN
(1 year)
Gait analysis: effects on
kinematics and
spatio-temporal variables
NA (note: from the same series of Stefani et al., 2007)
Moro et al.
(2010b)
N =6 Unilat. PPN
(3–12 months)
Significant reduction in
falls
NA
Ferraye et al.
(2010)
N =6 Bilateral PPN (plus
previous STN)
(4–12 months)
Variable effects on gait
disorder
NA
Arnulf et al.
(2010)
N =2 (1-year
follow up)
Bilateral PPN (on
previous STN)
Improvement of FOG and
falls
LFS increases alertness, HFS induces non-REM sleep.
The sudden withdrawal of LFS is followed by REM sleep
episodes (note: from the same series of Ferraye)
Strafella et al.
(2008)
N =1 Unilat. PPN (3 months) Improved motor function PET study: significant increase of rCBF in sub-cortical
areas, mostly thalamus, bilaterally
Ostrem et al.
(2010)
N =1 (PPFG) Bilateral PPN (1 year) Only mild improvement of
freezing and gait
impairment
NA
Costa et al.
(2010)
N =5 Bilateral PPTg and STN
(3 months)
29% reduction of UPDRS
part-III score
Significant improvement in working memory (note: same
cohort as Stefani et al., 2007)
Wilcox et al.
(2011)
N =1 (PPFG) Bilateral PPN Robust improvement of
gait and posture
NA
Pierantozzi
et al. (2008)
N =6 Bilateral PPTg and STN
(3–6 months)
Hoffman Reflex-Th.
increase
NA (note: same cohort as Stefani et al., 2007)
(Continued)
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Table 1 | Continued
Selected papers Patients DBS targeting
(and follow-up)
Motor symptoms Sleep and cognitive domains
Mazzone et al.
(2011)
N =17 13 Unilat. PPTg, 4 PPTg
plus GPi
NA
Brusa et al.
(2009)
1 PSP Unilat. PPTg (9 months) Negligible Marginal effect on cognitive domains (only minimal
improvement in verbal fluency)
Androulidakis
et al. (2008)
N =6 2 Bilateral PPN and STN NA; intrasurgical
neurophysiology
7-11 Hz oscillatory synchronization in PPN coupled with
cortical alpha2 Unilat. PPN and STN
1 Unilat. GPi and PPN
1 Unilat. PPN alone
Shimamoto
et al. (2010)
2 PD, 2 PSP ?
Thevathasan
et al. (2011)
5 PD with gait
freezing and
frequent falls)
Bilateral mid-lower PPN Significant improvement of
Gait and Falls
Questionnaire score; no
changes in akinesia scores
NA
Thevathasan
et al. (2010)
N =11 Significant benefit on gait
and balance, but not on
akinesia
Moderate improvement in attention (“speed – not
accuracy – of reaction” improved with stimulation)
PD, Parkinson’s disease; LFS, low-frequency stimulation; HFS, high frequency stimulation; PPTg, nucleus tegmenti pedunculopontini; PPN, pedunculopontine nucleus;
NA, not assessed.
Polysomnography (PSG) study (Romigi et al., 2008), whose results
were subsequently replicated (Alessandro et al., 2010). In these
studies, we investigated the specific effect of bilateral PPTg-DBS
on sleep structure of two PD patients by means of PSG recordings,
which were performed before and after surgery (STN-ON/PPTg-
OFF versus PPTg-ON/STN-OFF). The PSG data documented that,
before surgery, PD patients featured a severe sleep architecture
disruption, with frequent occurrence of nocturnal awakenings,
increased Stage I sleep and wakefulness after sleep onset (WASO),
plus a remarkable reduction of REM sleep time. In comparison
with pre-surgery, both bilateral STN-DBS and PPTg-DBS induced
the striking improved of sleep efficiency, with reduction of WASO
and nocturnal awakenings, together with a mild reduction of Stage
1 and increase of Stage 2 sleep. However, whereas STN-DBS had
no impact on REM sleep, only PPTg-DBS promoted a reduction
of REM latency and a relevant increase in REM sleep time (Romigi
et al., 2008; Alessandro et al., 2010).
These first PSG findings were soon confirmed by a succes-
sive electrophysiological study carried out in three PD patients
and two patients affected by progressive supra-nuclear palsy
(PSP) undergoing unilateral PPN-a DBS for prominent extra-
pyramidal axial signs (Lim et al., 2009). In all those patients,
it was found that PPN-a DBS, at both higher (70 Hz in PSP
patients) and lower (5–30 Hz in PD patients) frequency stimu-
lation, increased REM sleep time and REM percentage by induc-
ing more REM sleep periods, possibly lowering the REM sleep
threshold.
Although the local neuronal effects of DBS are still not fully
understood, the physio-pathogenesis of these PSG results may be
explained by considering that REM sleep is regulated via reci-
procally inhibitory REM “ON” and REM “OFF” nuclei, located
into the pontomesencephalic tegmentum (McCarley and Hob-
son, 1975), and that the PPN-a may promote REM by modulating
a brain-stem “flip-flop” switch, represented by the REM “ON”
sublaterodorsal and precoeruleus regions, and the REM “OFF”
lateral pontine tegmentum and ventrolateral periaqueductal gray
(Lu et al., 2006). In these patients, the active stimulating elec-
trodes were located into or near the PPN pars dissipata, and the
frequency of stimulation utilized was relatively low (5–70 Hz).
Hence, it has been inferred that PPN-a-ON may act on REM
sleep by increasing output from the REM “ON” PPN neurons,
and trans-synaptically inhibiting the REM “OFF” ventrolateral
periaqueductal gray (dorsomedial to PPN) and lateral pontine
tegmentum (lateral to PPN) region. In fact, LFS, in contrast with
HFS, could increase the firing discharge of neurons next to the
electrode (i.e., REM “ON” neurons), and excites, at the same time,
inhibitory pre-synaptic afferents to neurons at some distance from
the electrode (i.e., REM “OFF” neurons) (Johnson et al., 2008).
Moreover, an electrical coupling between PPN-a neurons and
both the parafascicular intralaminar nucleus and the subcoeruleus
nucleus, equally involved in cortical activation and REM sleep reg-
ulation, has been recently demonstrated as a novel mechanism
for sleep-awake control. The finding of electrical coupling in a
specific area of the reticular activating system endorses the con-
cept that this underlying process, behind specific neurotransmitter
interactions, modulates the firing activity across different cell pop-
ulations to induce changes in sleep-wake state (Garcia-Rill et al.,
2007; Heister et al., 2007).
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It is well known that PPN-a, part of the reticular activating
system, is characterized by powerful ascending cholinergic pro-
jections to the associative and non-specific intralaminar thalamic
nuclei, counting the centrolateral and the parafascicular neurons
(Kobayashi and Nakamura, 2003; Parent and Descarries, 2008),
which participate in modulating waking and REM sleep (Datta,
2002; Datta and Siwek, 2002). Within the thalamo-cortical sys-
tems, the PPN-cholinergic neurons, characterized by low (less
than 10 Hz) and high (20–80 Hz) rates of spontaneous tonic fir-
ing, exhibit their maximal firing activity during both REM sleep
and waking, which are associated with desynchronization of the
electroencephalogram (EEG) (Steriade et al., 1990a,b; Datta et al.,
2002). On the basis of PPN-a specific firing properties, intracellu-
lar recordings in animal models identified different types of thala-
mic projecting PPN-cholinergic cells, which are strictly related to
the genesis of the ponto-geniculo-occipital (PGO) waves, and thus
to the generation of REM sleep and REM sleep dependent cogni-
tive function (Steriade et al., 1990b; Datta et al., 2002; Datta, 2006).
Indeed, PGO waves are recorded during and immediately before
REM sleep from the pontine reticular formation, lateral genic-
ulate, and occipital cortex and represent the neurophysiological
index of mammalian REM sleep (Callaway et al., 1987). Intra-
cellular injection of cholinergic agonists (and/or kainate receptor)
demonstrated that kainate receptor agonists were able to increased
REM sleep, and at the same time, to generate PGO waves as a
consequence of the increased activity of PPN-cholinergic neurons
(Datta, 1997; Datta et al., 2002).
Aside these experimental studies, a recent elegant electrophys-
iological study carried out in a PD patient undergoing to unilat-
eral PPN-a DBS (Lim et al., 2009) supported the evidence that
PPN-stimulation exerts a possible REM-promoting effect. In this
patient, phasic potentials were simultaneously recorded from the
intrapontine depth DBS electrode and the scalp electrodes (24-
h video-PSG). These potentials have been identified exclusively
before and during the REM sleep, being partially associated to
the eye movement. Moreover, their morphology, temporal dis-
tribution, and localization were similar to those of PGO waves
occurring in other mammals, since their origin was recognized
in a restricted region of the pontomesencephalic tegmentum and
were invariably followed by characteristic cortical potentials with
a latency of 20–140 ms. Taken together, these electrophysiological
data support the hypothesis that these waveforms correspond to
the pontine component of humans PGO waves and that the PPN-a
represent the PGO transferring regions (Datta, 1997).
In a recent clinical study, performed in two PD patients under-
going bilateral PPN-a DBS, it was observed that in awake state
PPN-a at 80 Hz induced sleep (Arnulf et al., 2010). Therefore,
to substantiate this clinical observation, a daytime PSG was per-
formed at different stimulator settings maintained for at least
5 min each with a 3-min stimulator deactivation between changes
in settings. PPN-a-LFS (10–25 Hz) promoted wakefulness in the
two patients, while PPN-a-HFS (80 Hz) induced sleepiness and,
thus, non-REM sleep (within 0.5–8 min). These data indicate that
LFS and HFS of PPN-neurons strongly modulate the activity of
the nucleus and its connections, resulting in opposite effects on
sleepiness and alertness. Unexpectedly, the same study also showed
that in one out of the two patients, the brisk ending of PPN-a-LFS
caused fast sleep onset and REM sleep within 3–6 min, which lasted
2.6–9 min, to be followed by spontaneous wakefulness. The pre-
cise origin of the unexpected of REM sleep induction after abrupt
withdrawal of LFS remains unclear, although the authors stated
that a more dorsal placement of the stimulator electrode took
place (Arnulf et al., 2010).
In a more recent study, we have investigated further the long-
lasting effects of PPTg-DBS (the definition chosen for our target,
as suggested in the introduction) on nocturnal sleep and diurnal
somnolence in five PD patients (Peppe et al., 2012). Of course, they
are still the patients of the original series (neurosurgical procedure
including targeting in both PPTg and STN, Stefani et al., 2007).
This latter analysis was focused on subjective sleep scales,
including the Parkinson’s disease sleep scale (PDSS), a specific
and comprehensive pragmatic clinical tool designed to address
the multi-factorial nature of sleep disturbances in PD (Chaudhuri
et al., 2002), and the Epworth sleepiness scale (ESS), an eight-
item self-reporting questionnaire assessing symptoms of diurnal
drowsiness (Johns, 1991). Following the study design, scales were
administered a week before surgery and then 3 months and 1 year
after surgery. Maintaining constantly ON the STN-DBS for ethi-
cal concerns, the investigation required three different patterns of
PPTg-DBS, each kept for 15 days: (1) condition OFF; (2) condi-
tion ON (PPTg stimulated 24 h a day); condition CYCLE (PPTg
stimulated 12 h at night). The most interesting results can be sum-
marized as it follows: (i) a significant improvement of nocturnal
sleep quality was observed at 3-month follow-up and, then, con-
firmed at 1-year follow-up in comparison to pre-surgery (true
in all DBS conditions, although prominent during PPTg cycle
stimulation; (ii) only PPTg-DBS, unlike STN-DBS, induced a
remarkable long-term improvement of patient daytime sleepi-
ness, as testified by the significant reduction of ESS score at 1-year
follow-up (Figure 2); (iii) the cyclic PPTg-DBS proved more effi-
cacious than the continuous one on some aspect of nocturnal
sleep, including nocturnal restlessness and psychosis (more details
on PDSS and ESS data can be found in Peppe et al., 2012). For
the scopes of this review, it is noteworthy that even the Pittsburgh
sleep quality index (PSQI), a self-rated clinical scale considered
an indicator of relevant sleep disturbances in general population
(Buysse et al., 1989), proved the positive influence of PPTg-DBS
on sleep-awake cycle. In fact, PSQI showed a remarkable and long-
lasting improvement of patient global sleep quality after surgery,
mostly noticeable during PPTg-DBS, as demonstrated by the sig-
nificant reduction of PSQI score observed after surgery (Figure 1).
Based on the different PPTg stimulus modalities explored, we indi-
cated the importance of stimulating this area during sleep, showing
that cyclic stimulation of the PPTg reveals a better efficacy on
PD patients’ sleep quality than the continuous one. Hence, we
hypothesized that the amelioration of sleep-awake cycle, clearly
evident after the 3-month follow-up (but more under CYCLE),
could be due to greater physiological stimulation of PPTg activity.
The fact that we found the same results (similar impact on daily
somnolence) with both stimulation (ON and CYCLE), at the 1-
year follow up, suggests a sort of ceiling effect. Finally, considering
that the same two patents who underwent PSGs study, showed a
remarkable reduction of EES score during PPTg-DBS, it is inter-
esting to hypothesize a relationship between the improvement in
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FIGURE 1 | Exemplary FDG consumption comparing, in the same PD subjects, the condition only PPTg-ON (left panel) versus the condition STN-ON
(imaging were performed in Pisa, under the supervision of Dr. Ceravolo and Dr.Volterrani; for details, see Ceravolo et al., 2011).
FIGURE 2 | Shown are mean results of Epworth sleepiness scale (ESS) in
original PD patients implanted a long-time ago (2006–2007) in both STN
and PPTg. Histograms refer to before surgery (T0), then 3 (T1), and
12 months (T2) following surgery completion. A modest but significant
amelioration of diurnal drowsiness is detected when PPTg-ON is introduced
(for details, see Peppe et al., 2012).
daytime sleepiness and the amelioration of REM sleep, especially
considering the PPTg central role in promoting arousal in addition
to REM sleep (Rye, 1997).
In conclusion, few studies have been performed in PD patients
to assess the objective and subjective changes in sleep-awake cycle
related to PPN-a DBS. Moreover, comparison of data is difficult
since they were carried out in a small number of subjects, fol-
lowing different surgical approaches and electrode placement and
using diverse stimulus parameters. Nevertheless, apart from possi-
ble discrepancies in patients’ motor outcome, there is a converging
evidence that PPN-DBS exerts a positive effect on sleep quality
and wakefulness as well as on nocturnal REM sleep, indicating
the central role of PPN-a in sleep physiology and sleep dysfunc-
tion in humans, as previously documented from experimental
studies.
Noteworthy, and despite our fascination around PPTg-
mediated effects on sleep, several therapeutic agents exist already
for advanced PD patients suffering alterations of sleep architecture,
and DBS should never represent a short-cut indication for this sort
of impairments.
PPN AND COGNITION
In our hands, PPTg-DBS, originally conceived as a strategy for
PD gait impairment, revealed a little influence on postural insta-
bility and gait impairment, but regularized sleep and influenced
cognitive performance. As a matter of fact, the contribution of
PPTg-LFS in changing gait parameters was not significant with
respect to STN-HFS (Moreau et al., 2009; Peppe et al., 2010).
Yet, both Toronto’s and Grenoble’s groups found more appeal-
ing and consistent results in their patient cohorts, with a single
mono-lateral target (Ferraye et al., 2010; Moro et al., 2010b).
Our initial observations (Mazzone et al., 2005, 2007; Stefani
et al., 2007) concerned PD patients under a double target protocol
(PPTg plus STN) and the following biases are possible: first, the
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implantation of multiple electrode catheters might contribute to
severe stereotactic “lesion-effect” (yet, negligible in the long run);
second, and more critical, is a sort of tautology: that the enroll-
ment criteria utilized once, in recruiting patients for such a novel
and potentially risky surgery, were influenced more by patient’s
motivation and absence of co-morbidity rather than the severity
of LD-resistant sings (i.e., axial) and or the presence of freezing
of gait (FOG, see Stefani et al., 2007). At least two of our first
patients were indeed recruited despite disease duration <10 years
and despite scarce FOG. In other words, how could it be possible to
judge the specific PPN-mediated influence on FOG in PD patients
manifesting only a modest degree of axial akinesia and/or the rare
incidence of falls (whilst it was statistically more pronounced in PD
confined to the wheelchair or experiencing several weekly falls)?
Accordingly, it is still possible, as advocated by others, that the
PD patients with an extremely severe postural imbalance and an
akinetic profile less responsive to conventional drug therapy may
be ideal candidates for surgery aimed at implanting the pontine
structures. Moro et al. (2010b) have shown convincingly the clear
reduction of falling episode in the 1-year follow of mono-laterally
implanted PPN. In the Grenoble series, gait analysis results were
also promising (Ferraye et al., 2010, 2011). Mazzone is proceed-
ing with an extensive series of mono-lateral PPTg and gait results
seem more consistent (personal communication).
For the purpose of this review, PPTg-LFS, in our patients,
proved to have a potent effect on degree of attentiveness and some
specific cognitive performances. At odds with some adverse events
observed following STN-DBS (i.e., worsening of semantic and
phonemic fluency), PD patients under PPTg-LFS may experience a
significant amelioration of delayed recall, executive functions and
verbal fluency (Alessandro et al., 2010; Costa et al., 2010; Ceravolo
et al., 2011).
As recalled (Mazzone et al., 2011), “PPN lesion, in animals,
impairs attention, executive function, working memory (WM),
and learning” (on this issue, consider the pioneering review by
Anderson et al., 2006; Winn, 2006). However, anatomists suggested
that an abundant 30% PPN already degenerate in the early PD dis-
ease stages; apoptotic-like processes affect the PPN neuropil and
may represent a hallmark of extra-pyramidal syndrome. Hence,
how is it possible that DBS of a degenerated area is promoting
any effect? Reasonable answers include the preferential activa-
tion of PPN-fugal axonal fibers and the maintained functional
roles of surviving PPN neurons (Scarnati et al., 1987; Florio et al.,
2007).
The relevance of these findings emerges if compared to the
cognitive outcome of standard targets. Careful neuropsychologi-
cal examination in STN-implanted subjects may in fact disclose a
large percentage of subtle deficits in the post-surgery follow-up.
Some authors, at one extreme, demonstrated that >30% of STN-
DBS patients experienced a cognitive decline sufficient to identify
conversion to dementia (Williams et al., 2011). This finding repre-
sents a warning, although it did not reach significance with respect
to PD not submitted to neurosurgery (Williams et al., 2011).
Are these deficits really and promptly impacting any patient’s
quality of life? Prolonged trials, conducted on patients implanted
also at younger age (consider the series by Castrioto et al., 2011
and see Vitek, 2012) or preliminary data from the early stim group,
a multi-center investigation on about 150 early onset PD, suggest
not overestimating this issue (Schuepbach et al., 2013).
Nevertheless, an honest reappraisal of the literature about STN-
DBS, even if performed by unbiased experts, admits the potential
increase of apathy, and some degree of impairment in non-verbal
recall, oral information processing speed, and semantic fluency
(Bronstein et al., 2011).
In this content, the PPN-mediated cognitive benefits are
remarkable, despite the small cohort and the relatively modest
effect.
We found no significant changes between pre-surgery and
PPTg-OFF/STN-OFF conditions (Ceravolo et al., 2011). Con-
versely, the condition PPTg-ON/STN-OFF significantly improved
cognition in different domains when compared to PPTg-
OFF/STN-OFF. PPTg-ON ameliorated verbal long-term memory,
assessed with the California Verbal Learning test delayed recall
(p< 0.025), and executive functions, as revealed by both TMT
(B-A p< 0.025) and verbal fluency (p< 0.001). Therefore, we did
conclude PPTg-DBS “fueled a significant cognitive improvement”
(Ceravolo et al., 2011).
Costa et al. (2010), in another study (Table 1), investigated the
WM functioning in the same subjects (five PD patients who under-
went simultaneous PPTg- and STN-DBS). PD patients were eval-
uated (in the morning at least 12 h after antiparkinsonian therapy
withdrawal) comparing two conditions: (i) after continuous PPTg
stimulation (OFF Therapy/ON PPN); (ii) 120 min after PPTg had
been switched “OFF” (OFF Ther/OFF PPN). The experimental
WM task consisted of an n-back paradigm with verbal and visual-
object stimuli. PD patients manifested “a consistent response time
decrease on both the verbal and the visual-object tasks under
the PPTg-ON condition (p< 0.05).” However, the accuracy score
did not significantly differ between the two experimental con-
ditions. It was suggested that PPTg-stimulation “facilitates the
speed of processing of information in the content of WM, pos-
sibly through the modulation of the attentional resources” (Costa
et al., 2010).
As a corollary study, Zanini explored the possibility that com-
bined STN-HFS and PPTg-LFS influenced language. This study
observed “an interesting trend toward reduction of ungrammati-
cal errors (particularly substitution of free and inflectional mor-
phemes)” when stimulating either STN (at 130 Hz) or PPTg at
20 Hz (Zanini et al., 2009; Table 1).
Which mechanisms may underlie this surprising pattern of
effects? Figure 1 compares paradigmatic PET, performed on the
same PD subject, before and during either STN-ON (180 Hz)
or PPTg-ON (25 Hz) (Figure 1). Such an extended and bilateral
activation of several cortical areas (including medial frontal struc-
tures) is intuitively detected. The most relevant findings could be
summarized as follows:
- An extensive and bilateral metabolic activation of several corti-
cal regions, including both medial and dorso-lateral area of the
frontal lobe (Figure 1);
- The mono-lateral activation of the ventral striatum (Figure 1);
- The decrease of metabolic activity in the left anterior cerebellum
(culmen, not shown) (Alessandro et al., 2010; Ceravolo et al.,
2011).
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However, to date, other groups, utilizing since the late 2000s a
mono-lateral (and more medial) target inside PPN-a, emphasized
rather different metabolic results (acquired with different tech-
nique). Strafella and co-authors described mostly a PPN-mediated
increase of metabolic activity – rCBF changes – on viciniori GPi
and thalamus (Strafella et al., 2008; Ballanger et al., 2009).
A possible limitation of our studies concerns the lack of com-
parative evaluations of the condition PPTg-ON versus pharmaco-
logical ON-state. Another bias could derive from the fact that few
consistent data are available, at present, on low-frequency STN-
related changes of cortical metabolic activity. Hence, there is not
sufficient ground to exclude, albeit unlikely, that a low-frequency
STIM of STN might re-propose metabolic changes similar to PPTg
(Stefani et al., 2010). A very recent contribution suggested, in four
patients with bilateral PPN and caudal zona incerta (cZi) DBS
electrodes that combined PPN/cZi stimulation produced a statis-
tically significant improvement in UPDRS-III score compared to
cZi stimulation alone, but only in the condition MED-ON (Khan
et al., 2012). Interestingly, “the concomitant PPN/cZi stimulation
had a cumulative effect on levels of rCBF, effectively combining
sub-cortical and cortical changes induced by stimulation of either
target in isolation” (Khan et al., 2012).
CONCLUSION
Limited experience worldwide impedes the drawing of conclusive
statements on the clinical efficacy of PPTg stimulation on both
motor and non-motor domains. Any straightforward assumption
is, in our opinion, quite presumptuous. Major effort should be
launched for assessing to what extent the impact on sleep and cog-
nition, as detailed in our hands, may in fact be replicated by other
teams utilizing different trajectories; for the time being, whether
some of the NM benefits described (i.e., changes of sleep structure)
are really target-dependent and/or, at least in part, frequency-
dependent, might be addressed. In addition, the significance of
clinical changes in cognitive performance need to be evaluated in
light of real changes in routine functional way of life (as explored
on dementia in Stefani et al., 2013). On-going studies and extended
follow-up will contribute at clarifying this issue.
Unfortunately, as we acknowledged, the current technologies
do not support the attribution of a specific effect to any specific
contact lead and it is difficult to speculate on which sub-cortical
pathways (Aravamuthan et al., 2007, 2008) or spinal circuitry
is involved, since the commercially available catheters affect a-
specifically a plethora of en passant circuits. Yet, and despite rather
different targets, the LFS of the “PPN region” implanted by Bris-
tol (Khan et al., 2012) and Rome (Ceravolo et al., 2011) seems to
provide quite similar impacts on cortical metabolism.
With the present procedures, nobody has ascertained, so far, to
what extent stimulation of PPN preferentially modulates and/or
activates specific neuronal phenotypes (gabaergic, glutamatergic,
cholinergic) or fibers.
That said, the pattern of responses detected in our original
cohort may be attributed to more selective activation of the
pontine cholinergic contingent (abundant in PPN-C/PPtg) and
explain the robust effect on sleep and behavioral state. In con-
trast, a more selective activation of dorsal and medial sub-regions
(likely targeted by Toronto’s and Grenoble’s series) may indeed
reflect into discrete regional activation of nearest basal ganglia
stations (Strafella et al., 2008) and solid effects on falls prevention
(Ferraye et al., 2010; Moro et al., 2010b; Thevathasan et al., 2012).
One critical aspect to mention is that the PPN region, in PD
patients as well as in atypical Parkinsonism, is affected by severe
neuro-pathological abnormalities; a loss of a 30–40% neurons is
supported by post-mortem studies. We are tempted to speculate
that large differences in clinical response might be attributed not
to neuro-functional targets per se but also to neuro-pathological
differences between patients, for example in terms of the severity
of cholinergic neuronal loss, correlated in turn with the severity
of axial symptoms (Rinne et al., 2008).
In other words, some discrepancies between groups (or even
in the same patient’s series) are possibly explained by the dif-
ferent degree of PPN neuronal loss as manifested along the
ponto-mesencephalic axis in each patient submitted to surgery.
We know that the “the activity of thalamic-projecting cholinergic
neurons of the PPN is consistent with their role in inducing and
maintaining thalamo-cortical activation associated with desyn-
chronization of the EEG during wakefulness and REM sleep”
(Steriade et al., 1990; Benarroch, 2013). What we do not know,
of course, is the abundance of the residual not degenerated con-
tingent of fibers potentially activated by LFS in each of our
patients.
Although results between groups appear divergent in many
respects, 6 years experience on PPN-a/PPTg stimulation, in
humans, corroborates the following statements:
1. Clinical results support the hypothesis that single, mono-lateral
PPTg-LFS is advisable and safe, as originally advocated by
Toronto’s group (Moro et al., 2010b);
2. The “pro-attentive pattern,” promoted by PPTg-ON in our first
series, is very peculiar if compared to detrimental or negligible
cognitive effects promoted by routine STN-HFS. This may sug-
gest that endogenous transmitters other than catecholamines
are involved when PPTg (and PPN-a in a broad sense) was stim-
ulated. In our opinion, a widespread activation of ascending
pathways (mostly cholinergic fibers toward intra-thalaminar
nuclei) is the key factor. The unequivocal demonstration would
demand verification, through micro-dialysis, of the on-going
release of Ach or catecholamines or the modulation of trophic
factors and/or nucleotides in main target areas of PPN-a (such
as GPi/SNr on one hand and CM/Pf on the other) (see for
example Fedele et al., 2001; Stefani et al., 2005, 2011).
3. The relevance of the PPTg-mediated benefits on the NM spec-
trum signs is intriguing and supports, albeit speculatively,
the working hypothesis that the stimulation of specific sub-
portions of the pontine tegmentum should be tested as a
therapeutic chance in severe extra-pyramidal syndrome, such
multi-system atrophy (Brusa et al., 2009; Mazzone et al., 2012b),
or neurological states dominated by vigilance defects.
Our original contention – PPTg as a potential trigger to fuel
endogenous circuitries targeting large thalamic and cortical areas –
might be either validated or decline in a few years, provided
that a combination of technically refined approaches, adjourned
peri-surgical imaging, better application of neuro-physiological
hallmarks in the postsurgical phase and data acquisition from
larger series take place.
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PRELIMINARY DISCLOSURE
This manuscript does not represent an evidence-based review and,
of course, it contains many subjective opinions. Only a larger
observations, a more extended follow-up and, possibly, shared
neurosurgical parameters, would allow, in the next future, more
clear conclusions.
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